TUFT1 and neoplasm: Furthermore, subcutaneous xenograft model was established by injecting TUFT1 knockdown or control HCC cells, and the results showed that HCC tumor growth in vivo was also inhibited by TUFT1 knockdown (Figure 2(g)).